# Diabetes Guideline (synthetic summary)
- GLP-1 receptor agonists are recommended for adults with T2DM insufficiently controlled on metformin, especially with ASCVD risk or weight reduction goals.
- Consider A1c thresholds and prior therapy exposure before escalation.
- Monitor A1c every 3 months; counsel on GI effects; avoid in history of medullary thyroid carcinoma or MEN2.
